5 July 2018

SA

M PL

E

FO

R

M

Stakeholders and Communication Division

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5545 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

Page 2/5

M PL

SA E R

FO

M

Page 3/5

M PL

SA E R

FO

M

Page 4/5

M PL

SA E R

FO

M

Page 5/5

M PL

SA E R

FO

M

Sample eligibility form - Patients and consumers - European ...

Jul 5, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone +44 (0)20 3660 ...

732KB Sizes 5 Downloads 309 Views

Recommend Documents

Sample eligibility form - Healthcare professionals - European ...
Jul 5, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone +44 (0)20 3660 ...

European Medicines Agency's interaction with patients, consumers ...
Jun 15, 2017 - training tools and materials and developing new ones ..... which is responsible for the assessment and monitoring of human ...... Alert Card).

European Medicines Agency's interaction with patients, consumers ...
Jun 15, 2017 - 10th anniversary of Patients' and Consumers' Working Party . ... 13. 1.8.2. Social media workshop . ... Information on EMA website . ...... “The PCWP in its ten years of existence has been a catalyst for a profound culture.

Report - Patients' and Consumers' Working Party (PCWP) - European ...
is delivered. The evidence to support personalised medicine may include so-called 'big data' and an additional challenge revolves around how data can.

Patients, consumers, healthcare professionals key figures - 2017
Collaboration supports transparency and trust in regulatory processes. Highlights of 2017. ○ First Public Hearing held at EMA. ○ Framework for collaboration ...

Consolidated final report on the activities of patients' and consumers ...
May 23, 2017 - Explore how to best acknowledge patient/consumer input in the context of ... In addition, the use of social media by patients to connect and .... Page 10 ...... an integral element of media strategy, not just for campaigns, but also.

Consolidated final report on the activities of patients' and consumers ...
May 23, 2017 - The EMA has a long history of involving adult patients in its work and ...... the education of HCPs' (i.e. Continuing Education and Continuous.

Recommendations on eligibility to PRIME scheme - European ...
Nov 16, 2016 - SME applicants are micro-, small-and medium-sized-enterprises ... of the scheme or with a format and content inadequate to support their.

Recommendations on eligibility to PRIME scheme - European ...
Sep 21, 2016 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5550. Send a question via our ... Advanced Therapy Oncology. Treatment of ...

Recommendations on eligibility to PRIME scheme - European ...
Nov 15, 2017 - Substance type Therapeutic area. Therapeutic indication. Type of data supporting request. Type of applicant. Autologous T lymphocyte- enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor

Recommendations on eligibility to PRIME scheme - European ...
Oct 18, 2017 - Additionally, the CHMP reviewed data on progress to proof of concept and confirmed eligibility for A4250 in the treatment of progressive familial intrahepatic cholestasis, which was initially granted eligibility to the scheme at early

Recommendations on eligibility to PRIME scheme - European ...
Apr 26, 2017 - supporting request. Type of applicant ... Name of the active substance, INN, common name, chemical name or company code. SME applicants ...

Recommendations on eligibility to PRIME scheme - European ...
3 days ago - Name*. Substance type. Therapeutic area. Therapeutic indication. Type of data supporting request. Type of applicant. Adeno-associated viral.

Recommendations on eligibility to PRIME scheme - European ...
May 24, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Name*. Substance type. Therapeutic area. Therapeutic indication.

Recommendations on eligibility to PRIME scheme - European ...
Jul 4, 2018 - *This indicates eligibility requests received but not started by EMA as they were deemed outside the scope of the scheme or with a format and ...

Recommendations on eligibility to PRIME scheme - European ...
Mar 1, 2017 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom ... active substance, INN, common name, chemical name or company code. ... of the scheme or with a format and content inadequate to support their.

Recommendations on eligibility to PRIME scheme - European ...
Sep 20, 2017 - Therapeutic indication. Type of data supporting request ... Clinical exploratory. Other. Biological ... + Clinical exploratory. + Clinical confirmatory.

Recommendations on eligibility to PRIME scheme - European ...
Feb 1, 2017 - Send a question via our website www.ema.europa.eu/contact. © European Medicines Agency ... domain deleted variant of human coagulation ...

Recommendations on eligibility to PRIME scheme - European ...
Mar 29, 2017 - SME. Chemical. Oncology. Treatment of locally advanced or ... the scope of the scheme or with a format and content inadequate to support.

Recommendations on eligibility to PRIME scheme - European ...
Jul 26, 2017 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United ... Name of the active substance, INN, common name, chemical name or company code. ... of the scheme or with a format and content inadequate to support.

2018 PRIME eligibility requests - European Medicines Agency
Send a question via our website www.ema.europa.eu/contact. © European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. 16 October 2017. EMA/675761/2017. Human Medicines Evaluation Division. PRIME eligibility re

Recommendations on eligibility to PRIME scheme - European ...
Dec 20, 2017 - Press office. Recommendations on eligibility to PRIME scheme. Adopted at the CHMP meeting of 11-14 December 2017. During its December 2017 ... requests received but not started by EMA as they were deemed outside the scope of the scheme

Recommendations on eligibility to PRIME scheme - European ...
Jun 29, 2016 - Name of the active substance, INN, common name, chemical name or company code. SME applicants are micro-, small-and medium-sized-enterprises ... of the scheme or with a format and content inadequate to support their.

EMA leaflet for patients - European Medicines Agency
authorisation application to EMA. Each new medicine is ... EMA encourages research and development of new ... in the EU, we have access to the best scientific.